112 related articles for article (PubMed ID: 38762191)
1. SLC11A1 promotes kidney renal clear cell carcinoma (KIRC) progression by remodeling the tumor microenvironment.
Wu D; Zhou Y; Shi X; Yi X; Sheng Z; Fan L; Ge J; Cheng W; Zhou W; He H; Fu D
Toxicol Appl Pharmacol; 2024 Jun; 487():116975. PubMed ID: 38762191
[TBL] [Abstract][Full Text] [Related]
2. Identify CTBP1-DT as an immunological biomarker that promotes lipid synthesis and apoptosis resistance in KIRC.
Li H; Fei M; Zhang Y; Xu Q; Feng R; Cao J; Qu Y; Xiao H
Gene; 2024 Jul; 914():148403. PubMed ID: 38521112
[TBL] [Abstract][Full Text] [Related]
3. LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription.
Xie X; Lin J; Fan X; Zhong Y; Chen Y; Liu K; Ren Y; Chen X; Lai D; Li X; Li Z; Tang A
Cell Death Dis; 2021 Feb; 12(2):201. PubMed ID: 33608495
[TBL] [Abstract][Full Text] [Related]
4. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
Zou X; Mo Z
Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261
[TBL] [Abstract][Full Text] [Related]
5. The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma.
Bai S; Wu Y; Yan Y; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
Int J Med Sci; 2020; 17(18):2917-2925. PubMed ID: 33173412
[No Abstract] [Full Text] [Related]
6. LINC00997, a novel long noncoding RNA, contributes to metastasis via regulation of S100A11 in kidney renal clear cell carcinoma.
Chang Y; Li N; Yuan W; Wang G; Wen J
Int J Biochem Cell Biol; 2019 Nov; 116():105590. PubMed ID: 31442606
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of MITD1 and Associates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
Chen C; Sheng Y
Technol Cancer Res Treat; 2021; 20():15330338211036233. PubMed ID: 34346239
[TBL] [Abstract][Full Text] [Related]
8. Troponin T1 in tumorigenesis and immune modulation: Insights into multiple cancers and kidney renal clear cell carcinoma.
Zhang Q; Hao L; Wang F; Yu Q; Wu S; Han C
J Cell Mol Med; 2024 Jun; 28(11):e18410. PubMed ID: 38853457
[TBL] [Abstract][Full Text] [Related]
9. NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling.
Yin L; Li W; Wang G; Shi H; Wang K; Yang H; Peng B
J Exp Clin Cancer Res; 2019 Aug; 38(1):343. PubMed ID: 31391070
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling.
Ye Y; Zhang F; Chen Q; Huang Z; Li M
Mol Carcinog; 2019 Feb; 58(2):279-292. PubMed ID: 30334578
[TBL] [Abstract][Full Text] [Related]
11. Differential expression and prognostic value of TLR4 in kidney renal clear cell carcinoma.
Hu Y; Gu Y; Song Y; Zhao Y; Wang J; Ma J; Sui F
Mol Cell Probes; 2024 Jun; 75():101959. PubMed ID: 38579915
[TBL] [Abstract][Full Text] [Related]
12. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment.
Jiang Z; Zhang W; Zeng Z; Tang D; Li C; Cai W; Chen Y; Li Y; Jin Q; Zhang X; Yin L; Liu X; Xu Y; Dai Y
Front Immunol; 2022; 13():926461. PubMed ID: 36311770
[TBL] [Abstract][Full Text] [Related]
14. CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients.
Liu T; Xia Q; Zhang H; Wang Z; Yang W; Gu X; Hou T; Chen Y; Pei X; Zhu G; He D; Li L; Xu S
Aging (Albany NY); 2020 Nov; 12(21):21809-21836. PubMed ID: 33177244
[TBL] [Abstract][Full Text] [Related]
15. Elevated CDC45 Expression Predicts Poorer Overall Survival Prognoses and Worse Immune Responses for Kidney Renal Clear Cell Carcinoma via Single-Cell and Bulk RNA-Sequencing.
Zhang X; Zhou J; Wang Y; Wang X; Zhu B; Xing Q
Biochem Genet; 2024 Jun; 62(3):1502-1520. PubMed ID: 37642814
[TBL] [Abstract][Full Text] [Related]
16. JAK3 is a potential biomarker and associated with immune infiltration in kidney renal clear cell carcinoma.
Liang F; Liang H; Li Z; Huang P
Int Immunopharmacol; 2020 Sep; 86():106706. PubMed ID: 32570038
[TBL] [Abstract][Full Text] [Related]
17. ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma.
Lin S; Chen Q; Tan C; Su M; Min L; Ling L; Zhou J; Zhu T
BMC Med Genomics; 2024 Jun; 17(1):153. PubMed ID: 38840097
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of CD45RO+CD8+ T cells is a diagnostic and prognostic biomarker for clear cell renal cell carcinoma.
Wu K; Zheng X; Yao Z; Zheng Z; Huang W; Mu X; Sun F; Liu Z; Zheng J
Aging (Albany NY); 2021 May; 13(10):14304-14321. PubMed ID: 34016791
[TBL] [Abstract][Full Text] [Related]
19. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.
Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M
Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of DBT suppresses the aggressiveness of renal clear cell carcinoma and correlates with immune infiltration.
Zhang C; Huang G; Yang J; Jiang Y; Huang R; Ye Z; Huang Y; Hu H; Xi X
Front Immunol; 2023; 14():1197011. PubMed ID: 37383233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]